Medicine Quality Alert: Class II Medicines Recall of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection) Batch No. A24GL002, Manufactured by Nixi Laboratories Pvt, Ltd
The Pharmacy and Poisons Board has mandated the recall of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection) Batch No. A24GL002, Manufactured by Nixi Laboratories Pvt, Ltd.
From: Pharmacy and Poisons Board
Published: 30th April 2026
Recall Reference Number: REC/2026/011
Recall Classification: Class II
Recall Level: Retail/Facility Level
Manufacturer: Nixi Laboratories Pvt, Ltd
LTR: Galaxy Pharmaceutical Ltd
Product name: Galaxy’s Bupimax Heavy
Active Pharmaceutical Ingredient: Bupivacaine Hydrochloride in Dextrose Injection
Affected counties: All
Affected Batches
S/N | Batch No | Mfg Date | Exp Date | Pack Size |
1. | A24GL002 | 09/2024 | 08/2026 | Ampoule |
Brief description of the problem
Following Post Market Surveillance activities, the Board conducted sampling of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection) Batch No. A24GL002. Upon analysis, the product batch failed to comply with the specifications of the pH test whereby the pH was 3.7 against the specification of between 4.0 and 6.5.
Action for healthcare professionals
Quarantine all remaining stock and stop further distribution, sale, issuing, or use of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection) Batch No. A24GL002 immediately, and contact Galaxy Pharmaceutical Ltd to arrange return.
Action for patients and caregivers
Patients are advised to talk to their healthcare professional if they have the above batch of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection).
Further Information
For any inquiries on consignments please contact Galaxy Pharmaceutical Ltd, by email at info@galaxypharma.co.ke or via telephone at +254 (0) 20 374 8551-2-3-4
Promptly report any case/s of suspected substandard and falsified products or adverse reactions or insufficient control of symptoms to the nearest healthcare facility or the Pharmacy and Poisons Board through the following channels:
- https://pv.pharmacyboardkenya.org/users/mpublic
- USSD code at *271#
- Email pv@ppb.go.ke or pms@ppb.go.ke
- Telephone No. 0795743049
- Mobile application: mPvERS both Android and iOS
For any further enquiries and feedback on the product recall, contact the post-marketing surveillance unit at the Pharmacy and Poisons Board via email at pms@ppb.go.ke
Download Document
Medicine Quality Alert: Class II Medicines Recall of Galaxy’s Bupimax Heavy (Bupivacaine Hydrochloride in Dextrose Injection) Batch No. A24GL002, Manufactured by Nixi Laboratories Pvt, Ltd